These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26605982)

  • 21. Application of desirability-based multi(bi)-objective optimization in the design of selective arylpiperazine derivates for the 5-HT1A serotonin receptor.
    Machado A; Tejera E; Cruz-Monteagudo M; Rebelo I
    Eur J Med Chem; 2009 Dec; 44(12):5045-54. PubMed ID: 19846239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.
    Weber KC; Salum LB; Honório KM; Andricopulo AD; da Silva AB
    Eur J Med Chem; 2010 Apr; 45(4):1508-14. PubMed ID: 20133028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.
    Canale V; Guzik P; Kurczab R; Verdie P; Satała G; Kubica B; Pawłowski M; Martinez J; Subra G; Bojarski AJ; Zajdel P
    Eur J Med Chem; 2014 May; 78():10-22. PubMed ID: 24675176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT
    Guariento S; Franchini S; Tonelli M; Fossa P; Sorbi C; Cichero E; Brasili L
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):214-230. PubMed ID: 28114832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione.
    Żmudzki P; Chłoń-Rzepa G; Bojarski AJ; Zygmunt M; Kazek G; Mordyl B; Pawłowski M
    Arch Pharm (Weinheim); 2015 Apr; 348(4):229-41. PubMed ID: 25773578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands.
    Luo M; Wang XS; Roth BL; Golbraikh A; Tropsha A
    J Chem Inf Model; 2014 Feb; 54(2):634-47. PubMed ID: 24410373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
    López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
    Bioorg Med Chem; 2004 Oct; 12(19):5181-91. PubMed ID: 15351401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CoMFA methodology in structure-activity analysis of hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives based on affinity towards 5-HT1A, 5-HT2A and alpha1-adrenergic receptors.
    Maciejewska D; Zołek T; Herold F
    J Mol Graph Model; 2006 Nov; 25(3):353-62. PubMed ID: 16542863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of chromatographic data in QSAR Studies of 3-[ω-(4-Arylpiperazin-1-yl)alkyl]pyrimido[5,4-c]quinolin-4(3H)-one derivatives as 5-HT1A receptor ligands.
    Żydek G; Brzezińska E; Stańczak A; Lewgowd W
    J Chromatogr Sci; 2014 Aug; 52(7):596-603. PubMed ID: 23804019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
    Cappelli A; Manini M; Valenti S; Castriconi F; Giuliani G; Anzini M; Brogi S; Butini S; Gemma S; Campiani G; Giorgi G; Mennuni L; Lanza M; Giordani A; Caselli G; Letari O; Makovec F
    Eur J Med Chem; 2013 May; 63():85-94. PubMed ID: 23466604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D-QSAR study indicates an enhancing effect of membrane ions on psychiatric drugs targeting serotonin receptor 5-HT1A.
    Avram S; Milac AL; Mihailescu D
    Mol Biosyst; 2012 Apr; 8(5):1418-25. PubMed ID: 22373544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New arylpiperazines with flexible versus partly constrained linker as serotonin 5-HT(1A)/5-HT(7) receptor ligands.
    Kowalski P; Mitka K; Jaśkowska J; Duszyńska B; Bojarski AJ
    Arch Pharm (Weinheim); 2013 May; 346(5):339-48. PubMed ID: 23609855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.
    Grychowska K; Masurier N; Verdié P; Satała G; Bojarski AJ; Martinez J; Pawłowski M; Subra G; Zajdel P
    Chem Biol Drug Des; 2015 Oct; 86(4):697-703. PubMed ID: 25684690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
    Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The design and preparation of metabolically protected new arylpiperazine 5-HT1A ligands.
    Tandon M; O'Donnell MM; Porte A; Vensel D; Yang D; Palma R; Beresford A; Ashwell MA
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1709-12. PubMed ID: 15026055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part III.
    Herold F; Król M; Kleps J
    Acta Pol Pharm; 2004; 61(2):139-50. PubMed ID: 15493297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
    Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
    Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.